This article was published online on August 21, 2012. An error was subsequently identified. This notice is included in the online and print versions to indicate that both have been corrected October 2, 2012.
Article first published online: 21 AUG 2012
Copyright © 2012 Wiley Periodicals, Inc.
Pediatric Blood & Cancer
Volume 60, Issue 2, pages 254–257, February 2013
How to Cite
Escherich, G., Zimmermann, M., Janka-Schaub, G. and on behalf of the CoALL study group (2013), Doxorubicin or daunorubicin given upfront in a therapeutic window are equally effective in children with newly diagnosed acute lymphoblastic leukemia. A randomized comparison in trial CoALL 07-03. Pediatr. Blood Cancer, 60: 254–257. doi: 10.1002/pbc.24273
Conflict of Interest: Nothing to report.
- Issue published online: 14 DEC 2012
- Article first published online: 21 AUG 2012
- Manuscript Accepted: 9 JUL 2012
- Manuscript Received: 22 FEB 2012
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.